General NewsHealthcare

Global Rosacea Treatment Market Overview and Forecast 2020|Colorescience, Inc., Perrigo Company plc, Aclaris Therapeutics, Inc., Lupin Pharmaceuticals

Global rosacea treatment market is rising gradually with a steady CAGR of 3.8% in the forecast period of 2019-2026. High prevalence of rosacea, growing awareness about its therapeutic and increasing research and development for novel therapies for treatment are some major factors that drive the market growth.

The rosacea treatment report puts light on the change in the market which is taking place due to the moves of key players and brands such as product launches, joint ventures, mergers and acquisitions that in turn modifies the view of the global face of Pharmaceutical industry. This market report takes into account myriad of aspects of the market analysis which today’s businesses call for. To make the report outstanding, most up-to-date and advanced tools and techniques are used so that client achieves maximum benefits. The rosacea treatment report also includes the market drivers and market restraints that are derived from SWOT analysis.

Get Sample Copy Of This Report @  https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-rosacea-treatment-market

Few of the major competitors currently working in the global rosacea treatment market are Foamix Pharmaceuticals Ltd., ALLERGAN, Bausch Health, Sol-Gel Technologies Ltd., Bayer AG, Nestlé, PRUGEN, Merck & Co., Inc., AbbVie Inc., Unilever, Croda International Plc, Colorescience, Inc., Perrigo Company plc, Aclaris Therapeutics, Inc., Lupin Pharmaceuticals, Inc., Supernus Pharmaceuticals, Inc, Dr. Reddy’s Laboratories Ltd., Mylan N.V. among others.

Key Developments in the Market:

  • In August 2019, Foamix Pharmaceuticals Ltd. submitted a New Drug Application (NDA) to the U. S. FDA for FMX103 (minocycline) for the treatment of moderate-to-severe papulopustular rosacea. This application is based on the positive topline results of phase III clinical trials of FMX103. This drug candidate will be an efficacious treatment with a well-tolerated profile and will be present in a convenient topical foam formulation
  • In January 2017, ALLERGAN received the U. S. FDA approval for RHOFADE topical cream used for treatment of adults with persistent facial erythema associated with rosacea. The approval was based on two clinical trials which met the primary efficacy endpoint. This approval will provide ALLERGAN all the right for production and commercialization of this novel formulation.

Competitive Analysis:

Global rosacea treatment market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of rosacea treatment market for Global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.

Get Full Table Of content @   https://www.databridgemarketresearch.com/toc/?dbmr=global-rosacea-treatment-market

Market Drivers

  • Increasing government initiatives and investments in the treatment market will contribute in the market growth
  • Increasing research and development of advanced formulations for treatment of different types of rosacea and acne are expected to drive the market growth
  • Increasing prevalence rate of the disease acts as driver of market growth
  • Growing awareness about rosacea and its available therapeutics will increase the market size

Market Restraints

  • Multiple patent expiries brings a significant number of generic products that hampers the growth of market
  • Off-label usage of medicines for rosacea can also restrict the market growth
  • Rosacea is often underdiagnosed or misdiagnosed as acne hampers the market growth

Segmentation: Global Rosacea Treatment Market

By Type

  • Erythematotelangiectatic Rosacea
  • Papulopustular Rosacea
  • Ocular Rosacea
  • Phymatous Rosacea

By Drugs Class

  • Antibiotics
  • Immunosuppressants
  • Corticosteroids
  • Others

By Drugs

  • Rhofade
  • Mirvaso
  • Oracea
  • Others

By Route of Administration

  • Oral
  • Topical
  • Others

By End Users

  • Hospitals
  • Homecare
  • Specialty Clinics
  • Others

By Distribution Channels

  • Hospital Pharmacy
  • Online Pharmacy
  • Retail Pharmacy
  • Others

By Geography

  • North America
  • South America
  • Europe
  • Asia-Pacific
  • Middle East & Africa

Inquiry For Customize Report With Discount at :  https://www.databridgemarketresearch.com/inquire-before-buying/?dbmr=global-rosacea-treatment-market

About Data Bridge Market Research

An absolute way to forecast what future holds is to comprehend the trend today!

Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Data bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune. We ponder into the heterogeneous markets in accord with our clients needs and scoop out the best possible solutions and detailed information about the market trends. Data Bridge delve into the markets across Asia, North America, South America, Africa to name few.

Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate.

Contact:
Data Bridge Market Research
Tel: +1-888-387-2818
Email: [email protected]

 

 

Report Rating
Close